BATM Advanced Communications (BVC) Competitors

GBX 19.65
+0.78 (+4.11%)
(As of 05/3/2024 07:36 PM ET)

BVC vs. SPEC, TSTL, SCLP, DXRX, EAH, FUM, CEL, FARN, POLB, and KOO

Should you be buying BATM Advanced Communications stock or one of its competitors? The main competitors of BATM Advanced Communications include INSPECS Group (SPEC), Tristel (TSTL), Scancell (SCLP), Diaceutics (DXRX), ECO Animal Health Group (EAH), Futura Medical (FUM), Celadon Pharmaceuticals (CEL), Faron Pharmaceuticals Oy (FARN), Poolbeg Pharma (POLB), and Kooth (KOO). These companies are all part of the "medical" sector.

BATM Advanced Communications vs.

BATM Advanced Communications (LON:BVC) and INSPECS Group (LON:SPEC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

In the previous week, BATM Advanced Communications' average media sentiment score of 0.00 equaled INSPECS Group'saverage media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
INSPECS Group Neutral

BATM Advanced Communications has a net margin of -0.16% compared to INSPECS Group's net margin of -0.59%. BATM Advanced Communications' return on equity of -0.17% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.16% -0.17% 0.59%
INSPECS Group -0.59%-1.10%-0.03%

BATM Advanced Communications has higher earnings, but lower revenue than INSPECS Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£122.83M0.70£2.51MN/AN/A
INSPECS Group£202M0.31-£1.19M-£0.02-3,081.35

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

BATM Advanced Communications received 185 more outperform votes than INSPECS Group when rated by MarketBeat users. However, 100.00% of users gave INSPECS Group an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%
INSPECS GroupOutperform Votes
5
100.00%
Underperform Votes
No Votes

41.8% of BATM Advanced Communications shares are held by institutional investors. Comparatively, 67.2% of INSPECS Group shares are held by institutional investors. 26.2% of BATM Advanced Communications shares are held by insiders. Comparatively, 25.6% of INSPECS Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BATM Advanced Communications has a beta of 0.57, suggesting that its share price is 43% less volatile than the S&P 500. Comparatively, INSPECS Group has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500.

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.1%. INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.6%. INSPECS Group pays out -5,000.0% of its earnings in the form of a dividend.

Summary

BATM Advanced Communications beats INSPECS Group on 9 of the 14 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

MetricBATM Advanced CommunicationsMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£85.71M£2.55B£4.69B£1.41B
Dividend Yield3.52%1.89%5.31%11.95%
P/E Ratio2,800.00320.34239.661,733.12
Price / Sales0.70174.582,390.60350,832.38
Price / Cash2.12107.4846.2232.84
Price / Book0.733.654.872.56
Net Income£2.51M£86.27M£98.93M£178.82M
7 Day Performance7.73%0.14%118.39%4.63%
1 Month Performance8.01%-3.93%114.97%2.40%
1 Year Performance-25.00%-1.49%130.34%12.72%

BATM Advanced Communications Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
0 of 5 stars
GBX 56
flat
N/A-52.7%£56.94M£202M-2,800.001,673
TSTL
Tristel
0.0754 of 5 stars
GBX 465
-1.1%
GBX 390
-16.1%
+36.0%£220.83M£39.49M3,576.92208
SCLP
Scancell
0 of 5 stars
GBX 8.92
-6.6%
N/A-40.2%£82.76M£5.27M-892.0051Gap Up
DXRX
Diaceutics
0 of 5 stars
GBX 99
-3.9%
GBX 150
+51.5%
+1.0%£83.83M£21.90M10,500.00151
EAH
ECO Animal Health Group
0 of 5 stars
GBX 110.50
+0.5%
N/A-8.2%£74.85M£88.46M-5,525.00234
FUM
Futura Medical
0 of 5 stars
GBX 32.95
-5.5%
N/A-28.0%£99.33M£1.70M-1,647.5012Gap Up
CEL
Celadon Pharmaceuticals
0 of 5 stars
GBX 98
-4.4%
GBX 222.50
+127.0%
-28.8%£62.93M£11,258.00-753.8524Gap Up
FARN
Faron Pharmaceuticals Oy
0 of 5 stars
GBX 145
+3.6%
N/A-52.2%£99.77M£-725,000.00-345.2434Gap Up
POLB
Poolbeg Pharma
0 of 5 stars
GBX 12.05
+7.6%
N/A+89.4%£60.25MN/A-1,205.0012Gap Up
High Trading Volume
KOO
Kooth
0 of 5 stars
GBX 284
+5.2%
GBX 580
+104.2%
+13.7%£103.60M£33.34M-9,033.33478

Related Companies and Tools

This page (LON:BVC) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners